CannabisNewsBreaks

FridayAug 19, 2022 10:53 am

CannabisNewsBreaks – IBN, CannabisNewsWire to Shine the Spotlight on Cannabis Conference 2022

CannabisNewsWire (“CNW”), a specialized communications platform for the cannabis sector and one of the 50+ brands within IBN (“InvestorBrandNetwork”), today announced its reengagement by GIE Media to serve as a media sponsor for Cannabis Conference 2022. The unique event, presented by Cannabis Business Times, is slated to take place at the Paris Las Vegas Hotel & Casino in Las Vegas, Nevada, from Aug. 23-25, 2022. Industry participants from more than 30 countries will attend the globally acclaimed conference, which is dedicated to professionals of plant-touching businesses across the cannabis and hemp space. IBN and CannabisNewsWire will leverage their array of…

Continue Reading

ThursdayAug 18, 2022 3:39 pm

CannabisNewsBreaks – American Cannabis Partners Looking to Capitalize on Possible Future Federal Interstate Commerce Opportunities

American Cannabis Partners (“ACP”), a sustainable Jamaican experience canna-business innovator, is watching closely as the Marijuana Opportunity Reinvestment and Expungement (“MORE”) Act moves to the Senate, having passed the U.S. House of Representatives. The bill “would end the federal prohibition on cannabis by removing it from the list of banned controlled substances. ‘Cannabis is legal for adult use in 19 states and for medical use in 36 states… This bill would end the federal ban but leave legalization up to the states,’” a recent article that contains excerpts from a Forbes writeup reads. “American Cannabis Partners, along with other companies…

Continue Reading

ThursdayAug 18, 2022 2:14 pm

CannabisNewsBreaks – Advanced Container Technologies Inc.’s (ACTX) GrowPods Ideally Poised to Turn Tide Against Food Insecurity

Advanced Container Technologies (OTC: ACTX), the exclusive U.S. distributor of GrowPods, environmentally controlled micro-farms that allow cultivation of ultra-clean crops all year long, believes its products may be part of the solution to eradicate food insecurity and malnutrition. The World Food Program’s (“WFP”) vision for 2030 “calls for the world to eradicate food insecurity and malnutrition and for national and global actors to partner together to achieve several goals, including providing access to food and sustainable food systems. According to WFP, turning the tide against hunger includes, in part, ‘sustainable consumption and production to reduce food loss and waste,’” a…

Continue Reading

ThursdayAug 18, 2022 12:25 pm

CannabisNewsBreaks – Grapefruit USA Inc. (GPFT) Announces Progress on DLC Acquisition, Secures New Financing

Grapefruit USA (OTCQB: GPFT), an innovative California-based cannabiotech company, today updated its recent announcement of the proposed acquisition of Diagnostic Lab Corporation of Englewood Cliffs, New Jersey (“DLC”), a diversified food and agriculture safety company, as well as announced the recapitalization of the company. According to the update, Grapefruit is finalizing its due diligence on DLC and is in the final stages of negotiating the terms of its anticipated financing and structuring of the transaction documents, all of which it expects to complete in the next several weeks. “We are providing this update at this time to inform our many…

Continue Reading

WednesdayAug 17, 2022 2:42 pm

CannabisNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH Capable of Delivering APIs More Efficiently by Overcoming Food Effect

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced the allowance of a new patent in Japan, the fourth to be granted in that country and the 26th worldwide. “Entitled Lipophilic Active Agent Infused Compositions with Reduced Food Effect, this is the first patent issued from Lexaria’s seventh patent family and refers to tetrahydrocannabinol (‘THC’). The new patent acknowledges DehydraTECH(TM)’s ability to deliver active pharmaceutical ingredients (‘APIs’) more efficiently, in a process known as absorption, regardless of the presence of food in the gastrointestinal system. Ordinarily, food impacts drug absorption by physically interacting with drugs, altering the pH, stimulating bile flow, slowing…

Continue Reading

WednesdayAug 17, 2022 1:02 pm

CannabisNewsBreaks – Cilicon, Vape-Jet Collaborate to Deliver Intelligent, Integrated Vaporizer Solution

Cilicon, a global provider of cannabis vape hardware, together with Vape-Jet, a U.S.-based infrastructure platform for cannabis oil-filling, today announced the forming of an official partnership to provide an intelligent, one-stop product solution for global cannabis brands. With a mutual understanding of the value of technology for business growth in today’s digital economy, Cilicon and Vape-Jet have launched services for cannabis vaping tech development, hardware manufacturing and filling machines for all brands in the cannabis vaporization industry. The partnership aims to reduce the time and financial budget for industry practitioners focused on cannabis vaporization with smart technology and integrated services.…

Continue Reading

TuesdayAug 16, 2022 3:01 pm

CannabisNewsBreaks – AmeriCann Inc. (ACAN) Reports Record Net Income, Revenue

AmeriCann (OTCQB: ACAN), a cannabis company that develops state-of-the-art cultivation, product manufacturing and distribution facilities, has released its financial and operational results for its fiscal quarter ending June 30, 2022. According to the company, July revenue set an all-time monthly record. Numbers showed a significant increase in year-over-year quarterly net income and revenue, with both being records for the Company for the quarter ending June 2022. Revenue increased over 36% for the quarter ended June 2022 relative to the same quarter 2021, an increase of $213,188. Quarterly gross margins were 98.5%. The company attributed the increased revenue to products produced and…

Continue Reading

TuesdayAug 16, 2022 11:11 am

CannabisNewsBreaks – Flora Growth Corp. (NASDAQ: FLGC) Releases Financial Results for H1 2022

Flora Growth (NASDAQ: FLGC), a manufacturer and distributor of global cannabis products and brands, is reporting its financial and corporate results for the six months ending June 30, 2022. Highlights of the report include revenue for the company increasing 604% from the same period last year, reaching ~$15 million while gross profit for the company increased to ~$7 million, an increase of 547%. In the report, the company reaffirmed its 2022 revenue guidance of $35 million to $45 million, which represents an increase in projected revenue of between 300% to 400%. “In the first half of 2022, Flora delivered on…

Continue Reading

MondayAug 15, 2022 11:56 am

CannabisNewsBreaks – LFTD Partners Inc. (LIFD) Releases Q2 2022 Financial Report

LFTD Partners (OTCQB: LIFD), the corporate parent of leading cannabis and psychedelics manufacturer Lifted Made, is reporting on its second quarter 2022, which is the period ended June 30, 2022. Highlights of the report include revenue for the quarter totaling $16,776,502, a 151% increase from the $6,695,144 reported in Q2 2021, and an increase in operating margin of 3.14%, with Q2 2022 coming in at 26.40%. GAAP net income from the quarter increased — the eighth consecutive quarter of upward movement — totaling $3,219,460 up from $1,596,154 the same period last year. The company reported a 64% increase in basic…

Continue Reading

ThursdayAug 11, 2022 12:17 pm

CannabisNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Discusses Biotech Industry Valuation Metrics

Lexaria Bioscience (NASDAQ: LEXX, LEXXW) is a global innovator in drug delivery platforms. The company today issued information to its stakeholders as an aid to conveniently research and understand various non-affiliated third-party sources and their methodologies for valuing biotech and pharmaceutical companies. “Biotech companies with little to no revenue can still be worth billions,” Raphael Rottgen, CFA, FRM, was quoted in the press release. “While valuations can be extremely low or extremely high, there is often underlying logic in identifying risks and arriving at those valuations. Developing new drugs can have significant costs of over $1 billion and can take…

Continue Reading